Recent articles









What Happened in the Stock Market Today

On another record day for the major benchmarks, shares of Skechers skyrocketed on earnings and Celgene tumbled after discontinuing a drug trial.









How Big of a Deal Is Celgene's Flop?

A disappointing late-stage trial failure is causing shares to tumble, but there's a lot going on at this company that could pan out for investors.